QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli 期刊论文 JOURNAL OF NEPHROLOGY, 2016, 卷号: 29, 期号: 6 作者:  Wang, Wan-ning;  Xu, Hong-zhao;  Zhang, Yuan-yuan;  Cheng, Yan-li;  Xu, Zhong-gao 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Diabetic nephropathy  12(S)-HETE  Angiotensin II  Nephrin  P-cadherin   Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis 期刊论文 JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2016, 卷号: 17, 期号: [db:dc_citation_issue] 作者:  Zhu, Qianqian;  Li, Na;  Li, Fang;  Zhou, Zhihua;  Han, Qunying 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/02 angiotensin receptor blocker  liver fibrosis  treatment  Angiotensin-converting-enzyme inhibitors   Azilsartan, an angiotensin II type 1 receptor blocker, attenuates tert-butyl hydroperoxide-induced endothelial cell injury through inhibition of mitochondrial dysfunction and anti-inflammatory activity 期刊论文 NEUROCHEMISTRY INTERNATIONAL, 2016, 卷号: 94, 期号: [db:dc_citation_issue], 页码: 48-56 作者:  Liu, Hao;  Mao, Ping;  Wang, Jia;  Wang, Tuo;  Xie, Chang-Hou 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/02 eNOS  Mitochondrial dysfunction  Neuroprotection  PPAR-gamma  Azilsartan   Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis 期刊论文 International Journal of Cardiology, 2016, 期号: 205, 页码: 65-71 作者:  Wuxiang Xie;  Fanfan Zheng;  Xiaoyu Song;  Baoliang Zhong;  Li Yan 收藏  |  浏览/下载：37/0  |  提交时间：2016/10/17 Heart Failure And Reduced Ejection Fraction  Left Ventricular Dysfunction  Renin–angiotensin–aldosterone System   Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis 期刊论文 RENAL FAILURE, 2016, 卷号: 38, 期号: 6, 页码: 849-856 作者:  Zhao, Hong-Jin;  Li, Yan;  Liu, Shan-Mei;  Sun, Xiang-Guo;  Li, Min 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/17 All-cause mortality  angiotensin-converting enzyme inhibitor  angiotensin-II receptor blocker  calcium-channel blocker  chronic kidney  disease  end-stage renal disease